All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF1485 | Anti-Human VEGFR2 (XW-565) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-565 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1486 | Anti-Human VEGFR2 (XW-566) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-566 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1487 | Anti-Human VEGFR2 (XW-567) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-567 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1488 | Anti-Mouse VEGFR2 (XW-568) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-568 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1489 | Anti-Human VEGFR2 (XW-569) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-569 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1490 | Anti-Human VEGFR2 (XW-570) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-570 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1491 | Anti-Mouse VEGFR2 (XW-571) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-571 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1492 | Anti-Human VEGFR2 (XW-572) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-572 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2405 | Anti-Human VEGFR2 (XW-565) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-565 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2406 | Anti-Human VEGFR2 (XW-566) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-566 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2407 | Anti-Human VEGFR2 (XW-567) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-567 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2408 | Anti-Mouse VEGFR2 (XW-568) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-568 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2409 | Anti-Human VEGFR2 (XW-569) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-569 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8399 | TS-Fluc Anti-Human VEGFR2 scFv (XW-565) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-565 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8400 | TS-Fluc Anti-Human VEGFR2 scFv (XW-566) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-566 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8401 | TS-Fluc Anti-Human VEGFR2 scFv (XW-567) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-567 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8402 | TS-Fluc Anti-Mouse VEGFR2 scFv (XW-568) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-568 | Rat | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8403 | TS-Fluc Anti-Human VEGFR2 scFv (XW-569) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-569 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8404 | TS-Fluc Anti-Human VEGFR2 scFv (XW-570) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-570 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8405 | TS-Fluc Anti-Mouse VEGFR2 scFv (XW-571) CD28-CD3ζ CAR, pCDCAR1 | Mouse | XW-571 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION